The soluble 60-kDa tumour necrosis factor receptor: no difference found between patients with relapsing-remitting multiple sclerosis and controls: increasing levels are associated with the recovery from Guillain-Barré syndrome

1998 ◽  
Vol 245 (12) ◽  
pp. 803-808 ◽  
Author(s):  
T. Patzold ◽  
Eckhart Sindern ◽  
Ludgera Ossege-Pohle ◽  
Jean-Pierre Malin
Keyword(s):  
Multiple Sclerosis ◽  
Tumour Necrosis Factor ◽  
Tumour Necrosis ◽  
Guillain Barre Syndrome ◽  
Tumour Necrosis Factor Receptor ◽  
Relapsing Remitting ◽  
Remitting Multiple Sclerosis ◽  
Guillain Barré ◽  
Relapsing Remitting Multiple Sclerosis ◽  
Necrosis Factor

Tumor necrosis factor α and its receptors in relapsing-remitting multiple sclerosis

1997 ◽  
Vol 152 (1) ◽  
pp. 51-61 ◽  
Author(s):  
Gianvito Martino ◽  
Antonella Consiglio ◽  
Diego M Franciotta ◽  
Angelo Corti ◽  
Massimo Filippi ◽  
...  
Keyword(s):  
Multiple Sclerosis ◽  
Tumor Necrosis Factor ◽  
Tumor Necrosis ◽  
Tumor Necrosis Factor Α ◽  
Relapsing Remitting ◽  
Remitting Multiple Sclerosis ◽  
Factor Α ◽  
Relapsing Remitting Multiple Sclerosis ◽  
Necrosis Factor

scholarly journals Circulating Th17, Th22, and Th1 Cells Are Elevated in the Guillain-Barré Syndrome and Downregulated by IVIg Treatments

2014 ◽  
Vol 2014 ◽  
pp. 1-10 ◽  
Author(s):  
Shujuan Li ◽  
Tao Jin ◽  
Hong-Liang Zhang ◽  
Hong Yu ◽  
Fanhua Meng ◽  
...  
Keyword(s):  
Multiple Sclerosis ◽  
Intravenous Immunoglobulin ◽  
Acute Phase ◽  
Plasma Levels ◽  
Guillain Barre Syndrome ◽  
Th1 Cells ◽  
Th22 Cells ◽  
Relapsing Remitting ◽  
Remitting Multiple Sclerosis ◽  
Relapsing Remitting Multiple Sclerosis

The Guillain-Barré syndrome (GBS) is considered a T helper 1 (Th1) cells-mediated acute inflammatory peripheral neuropathy. However, some changes in GBS could not be explained completely by Th1 cells pathogenic role. Recently, Th17 cells have been identified and can mediate tissue inflammation and autoimmune response. Therefore, a study on the role of Th17 and Th22 cells and their cytokines in GBS is necessary for exploring the pathogenesis of GBS. Here, we detected the frequency of Th1, Th17, and Th22 cells by using 4-color flow cytometry and we detected the plasma levels of IL-17 and IL-22 by ELISA in GBS patients, relapsing-remitting multiple sclerosis patients at the acute phase of relapse, viral encephalitis or meningitis patients and healthy controls. Our data showed that the frequency of circulating Th1, Th17, and Th22 cells was significantly increased in GBS patients. The plasma levels of IL-17 and IL-22 in GBS and relapsing-remitting multiple sclerosis at the acute phase of relapse were also markedly elevated. Enhanced circulating Th22 cells were correlated with GBS severity. Intravenous immunoglobulin therapy downregulated Th17, and Th22 cells and the plasma levels of IL-17 and IL-22 in GBS patients. Th17 and Th22 cells may be involved in the pathogenesis of GBS, and intravenous immunoglobulin mediates therapeutic effects by downregulating these cells and their cytokines.

Sign in / Sign up

Export Citation Format

Share Document